Loading…

K562 Human Erythroleukemia Cells Demonstrate Commitment

Commitment, ie, the decision to express a differentiated phenotype and to terminate proliferation irreversibly in the absence of inducer, was investigated in K562 human erythroleukemia cells. Cells were cultured for 0, 1. 2, 3, or 4 days with inducer and then plated in medium containing methylcellul...

Full description

Saved in:
Bibliographic Details
Published in:Blood 1985-04, Vol.65 (4), p.862-868
Main Authors: Rowley, Peter T., Ohlsson-Wilhelm, Betsy M., Farley, Barbara A.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c360t-6921a0b790156fa2bc8490053dc04b9cf280ff6de26e14ea3524756b69287ed03
cites
container_end_page 868
container_issue 4
container_start_page 862
container_title Blood
container_volume 65
creator Rowley, Peter T.
Ohlsson-Wilhelm, Betsy M.
Farley, Barbara A.
description Commitment, ie, the decision to express a differentiated phenotype and to terminate proliferation irreversibly in the absence of inducer, was investigated in K562 human erythroleukemia cells. Cells were cultured for 0, 1. 2, 3, or 4 days with inducer and then plated in medium containing methylcellulose without inducer. Daily after plating, hemoglobin content was scored by benzidine staining, and growth was assessed by estimating the cell number per colony. With all inducers used, three types of colonies were found, those containing only benzidine-positive cells, those containing only benzidine-negative cells, and those containing both cell types (mixed colonies). Thymidine produced a progressive increase in the percentage of positive and mixed colonies and a progressive fall in the percentage of negative colonies. Whereas negative colonies grew at an exponential rate with a generation time of about 20 hours, positive colonies reached an average maximum size of 16 cells, representing a total of four divisions. Butyrate had a similar effect, except that the rise was greater for mixed colonies than for positive colonies, and the plateau in positive colony size was less evident. In contrast, CO2 depletion or hemin treatment induced an increase in the fraction of cells staining benzidine positive that was lost rapidly upon removal of the inducing condition. Thus, of the four conditions, thymidine and butyrate caused commitment, whereas hemin and CO2 depletion did not. Thus K562 cells, like Friend cells, demonstrate commitment, but, unlike Friend cells, demonstrate a significant rate of commitment in the absence of inducer and hence form a significant percentage of mixed colonies with or without inducer.
doi_str_mv 10.1182/blood.V65.4.862.862
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76021199</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120835927</els_id><sourcerecordid>76021199</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-6921a0b790156fa2bc8490053dc04b9cf280ff6de26e14ea3524756b69287ed03</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMo6_rxC0ToQbx1naRt2hw8SP1YUfCiXkOaTjHaNGvSCv57s-7i0cPLHOZ5h-Eh5ITCgtKKXTS9c-3ilReLfFFxts4OmdOCVSkAg10yBwCe5qKk--QghHcAmmesmJFZJqgoKzYn5UPBWbKcrBqSG_89vnnX4_SB1qikxr4PyTVaN4TRqxGT2llrRovDeET2OtUHPN7OQ_Jye_NcL9PHp7v7-uox1RmHMeWCUQVNKYAWvFOs0VUuAIqs1ZA3Qnesgq7jLTKONEeVFSwvC97EXlViC9khOd_cXXn3OWEYpTVBx8fUgG4KsuTAKBUigtkG1N6F4LGTK2-s8t-Sglzrkr-6ZNQlcxlVrRNbp9vzU2Ox_ets_cT92XavglZ959WgTfjDBKVlVBqxyw2GUcWXQS-DNjhobI1HPcrWmX_f-AFU6IdW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76021199</pqid></control><display><type>article</type><title>K562 Human Erythroleukemia Cells Demonstrate Commitment</title><source>Elsevier ScienceDirect Journals</source><creator>Rowley, Peter T. ; Ohlsson-Wilhelm, Betsy M. ; Farley, Barbara A.</creator><creatorcontrib>Rowley, Peter T. ; Ohlsson-Wilhelm, Betsy M. ; Farley, Barbara A.</creatorcontrib><description>Commitment, ie, the decision to express a differentiated phenotype and to terminate proliferation irreversibly in the absence of inducer, was investigated in K562 human erythroleukemia cells. Cells were cultured for 0, 1. 2, 3, or 4 days with inducer and then plated in medium containing methylcellulose without inducer. Daily after plating, hemoglobin content was scored by benzidine staining, and growth was assessed by estimating the cell number per colony. With all inducers used, three types of colonies were found, those containing only benzidine-positive cells, those containing only benzidine-negative cells, and those containing both cell types (mixed colonies). Thymidine produced a progressive increase in the percentage of positive and mixed colonies and a progressive fall in the percentage of negative colonies. Whereas negative colonies grew at an exponential rate with a generation time of about 20 hours, positive colonies reached an average maximum size of 16 cells, representing a total of four divisions. Butyrate had a similar effect, except that the rise was greater for mixed colonies than for positive colonies, and the plateau in positive colony size was less evident. In contrast, CO2 depletion or hemin treatment induced an increase in the fraction of cells staining benzidine positive that was lost rapidly upon removal of the inducing condition. Thus, of the four conditions, thymidine and butyrate caused commitment, whereas hemin and CO2 depletion did not. Thus K562 cells, like Friend cells, demonstrate commitment, but, unlike Friend cells, demonstrate a significant rate of commitment in the absence of inducer and hence form a significant percentage of mixed colonies with or without inducer.</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood.V65.4.862.862</identifier><identifier>PMID: 3919782</identifier><language>eng</language><publisher>Washington, DC: Elsevier Inc</publisher><subject>Biological and medical sciences ; Butyrates - pharmacology ; Carbon Dioxide - blood ; Cell Differentiation ; Cell Line ; Hematologic and hematopoietic diseases ; Hemin - pharmacology ; Humans ; Leukemia, Erythroblastic, Acute - pathology ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Medical sciences ; Thymidine - pharmacology ; Time Factors</subject><ispartof>Blood, 1985-04, Vol.65 (4), p.862-868</ispartof><rights>1985 American Society of Hematology</rights><rights>1985 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-6921a0b790156fa2bc8490053dc04b9cf280ff6de26e14ea3524756b69287ed03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006497120835927$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=9117143$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3919782$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rowley, Peter T.</creatorcontrib><creatorcontrib>Ohlsson-Wilhelm, Betsy M.</creatorcontrib><creatorcontrib>Farley, Barbara A.</creatorcontrib><title>K562 Human Erythroleukemia Cells Demonstrate Commitment</title><title>Blood</title><addtitle>Blood</addtitle><description>Commitment, ie, the decision to express a differentiated phenotype and to terminate proliferation irreversibly in the absence of inducer, was investigated in K562 human erythroleukemia cells. Cells were cultured for 0, 1. 2, 3, or 4 days with inducer and then plated in medium containing methylcellulose without inducer. Daily after plating, hemoglobin content was scored by benzidine staining, and growth was assessed by estimating the cell number per colony. With all inducers used, three types of colonies were found, those containing only benzidine-positive cells, those containing only benzidine-negative cells, and those containing both cell types (mixed colonies). Thymidine produced a progressive increase in the percentage of positive and mixed colonies and a progressive fall in the percentage of negative colonies. Whereas negative colonies grew at an exponential rate with a generation time of about 20 hours, positive colonies reached an average maximum size of 16 cells, representing a total of four divisions. Butyrate had a similar effect, except that the rise was greater for mixed colonies than for positive colonies, and the plateau in positive colony size was less evident. In contrast, CO2 depletion or hemin treatment induced an increase in the fraction of cells staining benzidine positive that was lost rapidly upon removal of the inducing condition. Thus, of the four conditions, thymidine and butyrate caused commitment, whereas hemin and CO2 depletion did not. Thus K562 cells, like Friend cells, demonstrate commitment, but, unlike Friend cells, demonstrate a significant rate of commitment in the absence of inducer and hence form a significant percentage of mixed colonies with or without inducer.</description><subject>Biological and medical sciences</subject><subject>Butyrates - pharmacology</subject><subject>Carbon Dioxide - blood</subject><subject>Cell Differentiation</subject><subject>Cell Line</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hemin - pharmacology</subject><subject>Humans</subject><subject>Leukemia, Erythroblastic, Acute - pathology</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Medical sciences</subject><subject>Thymidine - pharmacology</subject><subject>Time Factors</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1985</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoMo6_rxC0ToQbx1naRt2hw8SP1YUfCiXkOaTjHaNGvSCv57s-7i0cPLHOZ5h-Eh5ITCgtKKXTS9c-3ilReLfFFxts4OmdOCVSkAg10yBwCe5qKk--QghHcAmmesmJFZJqgoKzYn5UPBWbKcrBqSG_89vnnX4_SB1qikxr4PyTVaN4TRqxGT2llrRovDeET2OtUHPN7OQ_Jye_NcL9PHp7v7-uox1RmHMeWCUQVNKYAWvFOs0VUuAIqs1ZA3Qnesgq7jLTKONEeVFSwvC97EXlViC9khOd_cXXn3OWEYpTVBx8fUgG4KsuTAKBUigtkG1N6F4LGTK2-s8t-Sglzrkr-6ZNQlcxlVrRNbp9vzU2Ox_ets_cT92XavglZ959WgTfjDBKVlVBqxyw2GUcWXQS-DNjhobI1HPcrWmX_f-AFU6IdW</recordid><startdate>198504</startdate><enddate>198504</enddate><creator>Rowley, Peter T.</creator><creator>Ohlsson-Wilhelm, Betsy M.</creator><creator>Farley, Barbara A.</creator><general>Elsevier Inc</general><general>The Americain Society of Hematology</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198504</creationdate><title>K562 Human Erythroleukemia Cells Demonstrate Commitment</title><author>Rowley, Peter T. ; Ohlsson-Wilhelm, Betsy M. ; Farley, Barbara A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-6921a0b790156fa2bc8490053dc04b9cf280ff6de26e14ea3524756b69287ed03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1985</creationdate><topic>Biological and medical sciences</topic><topic>Butyrates - pharmacology</topic><topic>Carbon Dioxide - blood</topic><topic>Cell Differentiation</topic><topic>Cell Line</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hemin - pharmacology</topic><topic>Humans</topic><topic>Leukemia, Erythroblastic, Acute - pathology</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Medical sciences</topic><topic>Thymidine - pharmacology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rowley, Peter T.</creatorcontrib><creatorcontrib>Ohlsson-Wilhelm, Betsy M.</creatorcontrib><creatorcontrib>Farley, Barbara A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rowley, Peter T.</au><au>Ohlsson-Wilhelm, Betsy M.</au><au>Farley, Barbara A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>K562 Human Erythroleukemia Cells Demonstrate Commitment</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>1985-04</date><risdate>1985</risdate><volume>65</volume><issue>4</issue><spage>862</spage><epage>868</epage><pages>862-868</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>Commitment, ie, the decision to express a differentiated phenotype and to terminate proliferation irreversibly in the absence of inducer, was investigated in K562 human erythroleukemia cells. Cells were cultured for 0, 1. 2, 3, or 4 days with inducer and then plated in medium containing methylcellulose without inducer. Daily after plating, hemoglobin content was scored by benzidine staining, and growth was assessed by estimating the cell number per colony. With all inducers used, three types of colonies were found, those containing only benzidine-positive cells, those containing only benzidine-negative cells, and those containing both cell types (mixed colonies). Thymidine produced a progressive increase in the percentage of positive and mixed colonies and a progressive fall in the percentage of negative colonies. Whereas negative colonies grew at an exponential rate with a generation time of about 20 hours, positive colonies reached an average maximum size of 16 cells, representing a total of four divisions. Butyrate had a similar effect, except that the rise was greater for mixed colonies than for positive colonies, and the plateau in positive colony size was less evident. In contrast, CO2 depletion or hemin treatment induced an increase in the fraction of cells staining benzidine positive that was lost rapidly upon removal of the inducing condition. Thus, of the four conditions, thymidine and butyrate caused commitment, whereas hemin and CO2 depletion did not. Thus K562 cells, like Friend cells, demonstrate commitment, but, unlike Friend cells, demonstrate a significant rate of commitment in the absence of inducer and hence form a significant percentage of mixed colonies with or without inducer.</abstract><cop>Washington, DC</cop><pub>Elsevier Inc</pub><pmid>3919782</pmid><doi>10.1182/blood.V65.4.862.862</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 1985-04, Vol.65 (4), p.862-868
issn 0006-4971
1528-0020
language eng
recordid cdi_proquest_miscellaneous_76021199
source Elsevier ScienceDirect Journals
subjects Biological and medical sciences
Butyrates - pharmacology
Carbon Dioxide - blood
Cell Differentiation
Cell Line
Hematologic and hematopoietic diseases
Hemin - pharmacology
Humans
Leukemia, Erythroblastic, Acute - pathology
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
Thymidine - pharmacology
Time Factors
title K562 Human Erythroleukemia Cells Demonstrate Commitment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T02%3A36%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=K562%20Human%20Erythroleukemia%20Cells%20Demonstrate%20Commitment&rft.jtitle=Blood&rft.au=Rowley,%20Peter%20T.&rft.date=1985-04&rft.volume=65&rft.issue=4&rft.spage=862&rft.epage=868&rft.pages=862-868&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood.V65.4.862.862&rft_dat=%3Cproquest_cross%3E76021199%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c360t-6921a0b790156fa2bc8490053dc04b9cf280ff6de26e14ea3524756b69287ed03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=76021199&rft_id=info:pmid/3919782&rfr_iscdi=true